Cutaneous T-Cell Lymphoma medications
In this page you will find the list of drugs approved by the FDA to treat Cutaneous T-Cell Lymphoma.
alemtuzumab (Campath)
Monoclonal Antibodies
Learn More arrow_right_alt
Belinostat (Beleodaq)
Targeted Therapies
Learn More arrow_right_alt
brentuximab vedotin (Adcetris)
Antibody-Drug Conjugates
Learn More arrow_right_alt
cytarabine (Cytosar-U)
Chemotherapy Agents
Learn More arrow_right_alt
daunorubicin (Cerubidine)
Chemotherapy Agents
Learn More arrow_right_alt
doxorubicin (Adriamycin, Doxil)
Chemotherapy Agents
Learn More arrow_right_alt
methotrexate (Jylamvo, Trexall, Various, Xatmep)
Chemotherapy Agents
Learn More arrow_right_alt
mogamulizumab (Poteligeo)
Monoclonal Antibodies
Learn More arrow_right_alt
pralatrexate (Folotyn)
Chemotherapy Agents
Learn More arrow_right_alt
romidepsin (Istodax)
Targeted Therapies
Learn More arrow_right_alt
ruxolitinib (Jakafi, Jakavi, Opzelura)
Targeted Therapies
Learn More arrow_right_alt
Tofacitinib (Xeljanz)
Targeted Therapies
Learn More arrow_right_alt
Together we care.
Together we cure.
100% of every dollar you give supports our life-changing mission.